<DOC>
	<DOCNO>NCT00067561</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness different dose investigational medication woman severe diarrhea-predominant Irritable Bowel Syndrome ( IBS ) fail conventional therapy .</brief_summary>
	<brief_title>Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Alosetron</mesh_term>
	<criteria>Diagnosed severe diarrheapredominant Irritable Bowel Syndrome ( IBS ) . Failed conventional therapy . Willing make daily call touchtone telephone . Exclusion criterion : History current chronic severe constipation . Bloody diarrhea , abdominal pain rectal bleeding . Thrombophlebitis . Abnormal thyroid stimulate hormone ( TSH ) value . Alcohol and/or substance abuse within past two year . Pregnant lactating . History/treatment malignancy within past five year .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Dose-ranging</keyword>
	<keyword>Diarrhea-Predominant Irritable Bowel Syndrome</keyword>
	<keyword>d-IBS</keyword>
	<keyword>IBS</keyword>
	<keyword>Irritable Bowel Syndrome</keyword>
</DOC>